Cybin Inc. (CYBN)
NYSEAMERICAN: CYBN · Real-Time Price · USD
5.99
+0.04 (0.67%)
At close: Dec 5, 2025, 4:00 PM EST
6.05
+0.06 (0.97%)
After-hours: Dec 5, 2025, 8:00 PM EST
Cybin Market Cap
Cybin has a market cap or net worth of $298.92 million as of December 5, 2025. Its market cap has increased by 40.99% in one year.
Market Cap
298.92M
Enterprise Value
244.06M
1-Year Change
40.99%
Ranking
Category
Stock Price
$5.99
Market Cap Chart
Since November 11, 2020, Cybin's market cap has increased from $91.10M to $298.92M, an increase of 228.14%. That is a compound annual growth rate of 26.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 296.93M | 68.31% |
| Dec 31, 2024 | 176.41M | 4.62% |
| Dec 29, 2023 | 168.63M | 199.71% |
| Dec 30, 2022 | 56.26M | -72.57% |
| Dec 31, 2021 | 205.14M | 4.86% |
| Dec 31, 2020 | 195.64M | 114.76% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 927.87B |
| Johnson & Johnson | 495.83B |
| AbbVie | 401.80B |
| UnitedHealth Group | 302.33B |
| AstraZeneca | 282.37B |
| Novartis AG | 253.36B |
| Merck & Co. | 252.69B |
| Thermo Fisher Scientific | 219.29B |